Literature DB >> 15043893

Extensor pollicis longus tenosynovitis mimicking de Quervain's disease because of its course through the first extensor compartment: a report of 2 cases.

Yukio Abe1, Kazunari Tsue, Ei Nagai, Kousuke Katsube, Tomoyuki Miyoshi.   

Abstract

We present 2 cases of extensor pollicis longus tenosynovitis caused by the unusual course of the extensor pollicis longus tendon. The extensor pollicis longus tendon passed through the first extensor compartment and was constricted severely. The symptoms were similar to those of de Quervain's disease. The clinical presentation, diagnosis, and surgical technique of this very rare anatomic condition are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15043893     DOI: 10.1016/j.jhsa.2003.11.012

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  5 in total

1.  Variant course of extensor pollicis longus tendon in the second wrist extensor compartment.

Authors:  Young Jun Kim; Jae Hoon Lee; Jong Hun Baek
Journal:  Surg Radiol Anat       Date:  2015-08-08       Impact factor: 1.246

2.  Anomalous muscles within the first dorsal extensor compartment of the wrist.

Authors:  Christian J Zaino; Joshua T Mitgang; Mohini Rawat; Mukund R Patel
Journal:  Hand (N Y)       Date:  2014-12

3.  Extensor Pollicis Longus Injury in Addition to De Quervain's with Text Messaging on Mobile Phones.

Authors:  Charu Eapen; Bhaskaranand Kumar; Anil K Bhat; Anand Venugopal
Journal:  J Clin Diagn Res       Date:  2014-11-20

4.  Distal intersection syndrome progressing to extensor pollicis longus tendon rupture: a case report with sonographic findings.

Authors:  Ross Mattox; Patrick J Battaglia; Frank Scali; Kathy Ottolini; Norman W Kettner
Journal:  J Ultrasound       Date:  2016-12-08

5.  Anomalous course and stenosing tenosynovitis of the extensor pollicis longus tendon at the radial styloid process: A case report.

Authors:  Young-Keun Lee; Malrey Lee
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.